Deploying Artificial Intelligence (AI) to Improve R&D Productivity

Using Artificial Intelligence in biopharmaceutical R&D has the potential to lower costs, target patient populations more effectively, improve efficiency, and ultimately bring new medicines to market more quickly. Companies attending this session can learn more about the technology and human capital required to incorporate AI into their business operations. Speakers will provide information on data challenges, privacy concerns, and the regulatory environment.